(Q36283731)

13 August 2017

1 reference

title

Antibiotic resistance in Staphylococcus aureus and its relevance in therapy (English)

1 reference

13 August 2017

main subject

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

antibiotic resistance

1 reference

Abhijit M Bal

1

1 reference

13 August 2017

Ian M Gould

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Expert Opinion on Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

6

1 reference

13 August 2017

issue

13

1 reference

13 August 2017

page(s)

2257-2269

1 reference

QUANTITATIVE ACTION OF PENICILLIN INHIBITOR FROM PENICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCI.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Genome and virulence determinants of high virulence community-acquired MRSA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

The association between Staphylococcus aureus strains carrying panton-valentine leukocidin genes and the development of deep-seated follicular infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Has vancomycin-resistant Staphylococcus aureus started going it alone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Oxazolidinone antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Linezolid--a review of the first oxazolidinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Nucleotide sequence of a staphylococcal plasmid gene, vgb, encoding a hydrolase inactivating the B components of virginiamycin-like antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Role of quinupristin/dalfopristin in the treatment of Gram-positive nosocomial infections in haematological or oncological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Tigecycline: clinical evidence and formulary positioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Mechanism of action of oritavancin and related glycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus Endocarditis unresponsive to vancomycin therapy with linezolid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Linezolid in the treatment of Gram-positive prosthetic joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Peripheral neuropathy associated with prolonged use of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Efficacy and safety of linezolid in the treatment of skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Co-trimoxazole–Sensitive, Methicillin-ResistantStaphylococcus aureus, Israel, 1988–1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

DNA vaccination by mecA sequence evokes an antibacterial immune response against methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Alkyl gallates, intensifiers of beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Percutaneous treatment of chronic MRSA osteomyelitis with a novel plant-derived antiseptic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.13.2257

10.1517/14656566.6.13.2257

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference